Metreleptin and Lipodystrophy Data Presented at the Annual Meeting of the Endocrine Society
Apr 04, 2017 20:10 pm UTC| Business
VANCOUVER, British Columbia CAMBRIDGE, Mass., April 04, 2017 -- Novelion Therapeutics Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with...
Landec Corporation Reports Third Quarter and First Nine Months Fiscal 2017 Results
Apr 04, 2017 20:05 pm UTC| Business
MENLO PARK, Calif., April 04, 2017 -- Landec Corporation (NASDAQ:LNDC), a leading innovator of diversified health and wellness solutions within the packaged natural food and biomaterial markets, reported results for the...
DuPont Fabros Technology, Inc., Announces Date of First Quarter 2017 Earnings Release
Apr 04, 2017 20:05 pm UTC| Business
WASHINGTON, April 04, 2017 -- DuPont Fabros Technology, Inc. (NYSE:DFT), a leading, owner, developer, operator and manager of enterprise-class, carrier-neutral, large multi-tenant wholesale data centers, today announced...
Integra LifeSciences Announces Expansion of Credit Facility to include new $700 million term loan
Apr 04, 2017 20:05 pm UTC| Business
PLAINSBORO, N.J., April 04, 2017 -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that it has increased its credit facility with its bank group led...
AIT Therapeutics Inc. Raises Gross Proceeds of $10.9 Million and Completes Reverse Merger
Apr 04, 2017 20:01 pm UTC| Business
REHOVOT, Israel and NEW YORK, April 04, 2017 -- AIT Therapeutics Inc. (OTC:AITB), a clinical stage anti-microbial therapeutic company treating respiratory diseases, today announced that it raised an aggregate of...
Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares
Apr 04, 2017 20:01 pm UTC| Business
JERSEY, Channel Islands, April 04, 2017 -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it intends to commence an underwritten public offering of its ordinary shares. ...
Ohr Pharmaceutical Announces Proposed Public Offering of Common Stock and Warrants
Apr 04, 2017 20:01 pm UTC| Business
NEW YORK, April 04, 2017 -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that it intends to offer shares of its common stock and warrants to purchase shares...